| This week's sponsor is Premier Research. | | | Atopic Dermatitis: Where Do We Go From Here?
Improved understanding of atopic dermatitis is revealing new insights and treatment options. Get current by downloading our white paper examining these exciting and emerging therapies. Premier Research. It's what we do. Best. |
Today's Rundown Pfizer confirms neuro cuts as it swings the ax on a host of other early projects Shire bags rights to autoimmune drug to target multibillion-dollar IVIg market Corbus scores $25M from Cystic Fibrosis Foundation for 415-patient study EMA to lose 50% of its floor space in move to temporary Amsterdam home BridgeBio’s QED Therapeutics picks up discarded Novartis cancer drug Expect AbbVie's story to move from 'How much Humira?' to 'Who will it buy?': analyst Featured Story | | | Tuesday, January 30, 2018 Pfizer already forewarned that it was cutting jobs and projects out of its neuro unit. Now we have the full list of retired candidates, alongside a host of other experimental drugs up for the chop. |
|
|
| This week's sponsor is Dell EMC. | | | [Webinar] Is Your Life Science Data "F-A-I-R"?
Tuesday, February 13 | 2pm ET / 11am PT
Is Your Life Science Data "F-A-I-R"? Join DataFrameworks & Dell EMC in this webinar to discover a new approach to create scientific data that is findable, accessible, interoperable, and reusable. Register now! |
Top Stories Tuesday, January 30, 2018 Shire has secured the rights to a preclinical autoimmune candidate from AB Biosciences. The asset is a recombinant protein designed to improve on existing intravenous immunoglobulin (IVIg) therapies. Tuesday, January 30, 2018 The funding will carry Corbus' lenabasum through a 415-patient phase 2b trial measuring pulmonary exacerbations as its primary endpoint. Tuesday, January 30, 2018 The European Medicines Agency (EMA) will move into temporary accommodations half the size of its current home when it leaves London in 2019. That precipitous drop in the amount of space available to the EMA will force the agency to hold meetings off-site, but the agency expects its core operation to be insulated from the disruption. Tuesday, January 30, 2018 BridgeBio has licensed an abandoned cancer drug from Novartis and will develop it for FGFR-related diseases, including bile duct cancer and a form of dwarfism. Tuesday, January 30, 2018 AbbVie may not seem to most investors like the kind of company to chase down mammoth deals. But with Humira churning out billions every quarter, plus offshore cash on the way back to the U.S., it has the wherewithal to do just that, one analyst points out. Enrollment Showcase | | | Sponsored by: Drexel University Online Drexel University’s online graduate programs in biomedicine, clinical research, drug discovery, and molecular medicine were developed with working professionals in mind, providing you with the education, practical skills, and competitive edge you need to be successful in your career. Learn more. |
|
|
Resources Sponsored by: Agilent This Agilent intact protein analysis includes: Sponsored by: Seton Hall Don’t miss this educational program trusted by multi-national companies as part of their employee’s compliance training. Explore legal, regulatory and ethical issues faced by pharmaceutical, biotech and medical device manufacturers operating in the Asia-Pacific region. Visit event page for session topics. Presented by: Patheon Download Patheon’s whitepaper to discover two main areas where a drug developer can face significant obstacles during biologics development and how by evaluating these capabilities, it can answer the critical question of whether its in-house strategy is ready for these uncertainties. Presented by: SDC and Stiris Research What do you do when timelines are missed, data is dirty, and everyone is pointing fingers? Join this webinar to learn how to prevent, identify, and implement a successful clinical trial rescue. Sponsored by: Veeva Systems Expanding into new markets places a spotlight on inefficient processes. Sponsored by: Veeva Systems Regulatory leaders share challenges and best practices from a lack of standardization, manual processes, and fragmented systems. Sponsored by: WCG Selecting the right sites to conduct your clinical trials will determine the success or failure of meeting your enrollment goals. Sponsored by: Veeva Systems Read this guide if you’re a global life sciences company - conducting clinical trials across several countries, or manufacturing and distributing products in multiple regions - to learn five steps to align and improve quality oversight, as well as avoid common mistakes in harmonization initiatives. Presented By: Covance Global clinical trials are the trend and gaining in popularity, but running a global trial is not a straightforward process. This white paper explores some of the challenges associated with global clinical trials and considerations for ensuring that the collected data comply with the trial's overall objectives. Presented By: Charles River Join us as we discuss how Charles River Celsis® helped Labor L+S AG validate a 7-day membrane filtration sterility test using existing protocols. Presented By: Catalent Learn how Catalent Biologics is paving the way for flexible biologics development and manufacturing through advanced technologies and fully integrated multi-product facility. Presented By: Catalent Download the eBook to get articles from various Elsevier journals highlighting developments in ADC technology. Presented By: Catalent Learn how cell development and process scale-up can be optimized for antibodies requiring additional processing. Sponsored By: RTI Health Solutions In this webinar, we will introduce the rapidly-evolving within-subject clinical trial (WSCT) methods for early phase evidence generation that require fewer people, less time, and usually less funding than traditional early phase methods. Drug Approval, Manufacturing Quality & Regulation 2018 | Online TMF Operations: a Quality and Regulatory Approach March 19 - 21, 2018 | Berlin, Germany
Drug Development Boot Camp® 2018 November 14-15, 2018 | Boston, MA ICI Boston Summit 2018 March 19-21, 2018 | Boston, MA MIXiii-Biomed 2018 May 15-17, 2018 | Tel-Aviv, Israel Field Service Medical February 26-28, 2018 | Hilton La Jolla, Torrey Pines, CA | 